54275-3 |
Glucose^45M post dose ornithine alpha-ketoglutarate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose ornithine alpha-ketoglutarate |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
54275-3 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 45M p OKG SerPl-sCnc |
|
|
|
N |
|
2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; 45M p OKG; 45M p Orn; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
54276-1 |
Glucose^1H post dose ornithine alpha-ketoglutarate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose ornithine alpha-ketoglutarate |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
54276-1 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 1h p OKG SerPl-sCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 1h p OKG; 1h p Orn; 2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; 60 min; 60 minutes; 60M; 60min; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
54277-9 |
Glucose^1.5H post dose ornithine alpha-ketoglutarate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --1.5 hour post dose ornithine alpha-ketoglutarate |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
54277-9 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 1.5h p OKG SerPl-sCnc |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p OKG; 1.5h p Orn; 1.5Hr; 2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; 90 min; 90 minutes; 90M; 90min; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
54278-7 |
Glutarate |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Glutarate [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54278-7 |
|
|
|
|
Both |
|
|
|
0 |
Glutarate CSF-sCnc |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Glutaric acid; Level; Pentanedioiate; Pentanedioic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54279-5 |
Glutarylcarnitine (C5-DC)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Glutarylcarnitine (C5-DC)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54279-5 |
|
|
|
|
Both |
|
|
|
0 |
Glutarylcarn/Creat Ur-sRto |
|
|
|
N |
|
C5DC; C5-DC; Chemistry; CR; Crea; Creat; Dicarboxylic carnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
5428-8 |
CD11c |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD11c cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5428-8 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD11c WBC-aCnc |
|
|
|
|
|
AlphaX integrin chain; Arbitrary concentration; Axb2; CELL MARKERS; CR4; leukocyte surface antigen p150,95; Leukocytes; LeuM5; Leu-M5; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54280-3 |
Glutarylcarnitine (C5-DC) |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Glutarylcarnitine (C5-DC) [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54280-3 |
|
|
|
|
Both |
|
|
|
0 |
Glutarylcarn CSF-sCnc |
|
|
|
N |
|
C5DC; C5-DC; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54281-1 |
Glutarylcarnitine (C5-DC) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Glutarylcarnitine (C5-DC) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54281-1 |
|
|
|
|
Both |
|
|
|
0 |
Glutarylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C5DC; C5-DC; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54282-9 |
Glutarylcarnitine (C5-DC) |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Glutarylcarnitine (C5-DC) [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54282-9 |
|
|
|
|
Both |
|
|
|
0 |
Glutarylcarn Ur-sCnc |
|
|
|
N |
|
C5DC; C5-DC; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54283-7 |
Glycerol |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Glycerol [Mass/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
54283-7 |
|
|
|
|
Both |
|
|
|
0 |
Glycerol Fld-mCnc |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.7 |
2.27 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
54284-5 |
Glycerol |
SCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Glycerol [Moles/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
54284-5 |
|
|
|
|
Both |
|
|
|
0 |
Glycerol Fld-sCnc |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.73 |
2.27 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
54285-2 |
Glycerol |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Glycerol [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
54285-2 |
|
|
|
|
Both |
|
|
|
0 |
Glycerol Ur-sCnc |
|
|
|
N |
|
Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
54286-0 |
Glycolate |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Glycolate [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54286-0 |
|
|
|
|
Both |
|
|
|
0 |
Glycolate CSF-sCnc |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Glycolic acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54287-8 |
Guanidinoacetate |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Guanidinoacetate [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54287-8 |
|
|
|
|
Both |
|
|
|
0 |
Guanidinoacetate CSF-sCnc |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; GAA; glycocyamine; guanidinoacetic acid; guanidoacetic acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54288-6 |
Guanidinoacetate |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Guanidinoacetate [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54288-6 |
|
|
|
|
Both |
|
|
|
0 |
Guanidinoacetate Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; GAA; glycocyamine; guanidinoacetic acid; guanidoacetic acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54289-4 |
Hemoglobin |
MCnc |
Bld^BPU |
Pt |
Qn |
|
|
ACTIVE |
Hemoglobin [Mass/volume] in Blood from Blood product unit |
|
MIN |
DefinitionDescription |
|
|
g/dL |
|
|
|
|
|
|
HEM/BC |
|
54289-4 |
|
|
|
|
Both |
|
|
|
0 |
Hgb Bld BPU-mCnc |
|
|
|
N |
|
Blood; Blood product unit; Blood Product Unit (Pack); Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.7 |
2.27 |
|
|
|
|
|
|
|
g/dL |
|
|
|
0 |
5429-6 |
CD120a |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD120A cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5429-6 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD120a WBC-aCnc |
|
|
|
|
|
Arbitrary concentration; CELL MARKERS; Leukocytes; p55; Point in time; QNT; Quan; Quant; Quantitative; Random; TNFRI; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54290-2 |
Heptanoylcarnitine (C7)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Heptanoylcarnitine (C7)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54290-2 |
|
|
|
|
Both |
|
|
|
0 |
Heptanoylcarn/Creat Ur-sRto |
|
|
|
N |
|
C7; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
54291-0 |
Heptanoylcarnitine (C7) |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Heptanoylcarnitine (C7) [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54291-0 |
|
|
|
|
Both |
|
|
|
0 |
Heptanoylcarn CSF-sCnc |
|
|
|
N |
|
C7; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54292-8 |
Heptanoylcarnitine (C7) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Heptanoylcarnitine (C7) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54292-8 |
|
|
|
|
Both |
|
|
|
0 |
Heptanoylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C7; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54293-6 |
Heptanoylcarnitine (C7) |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Heptanoylcarnitine (C7) [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54293-6 |
|
|
|
|
Both |
|
|
|
0 |
Heptanoylcarn Ur-sCnc |
|
|
|
N |
|
C7; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54294-4 |
Fatty acids.very long chain.C26:0/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Fatty acids.very long chain C26:0 (Hexacosanoate)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54294-4 |
|
|
|
|
Both |
|
|
|
0 |
VLCFA C26:0/Creat Ur-sRto |
|
|
|
N |
|
Acd; Acid; Aliphatic carboxylate; C26:0; Cerotiate; Cerotic acid; Chains; Chemistry; Chn; CR; Crea; Creat; Fatty acid; Hexacosanoate; Hexacosanoic acid; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn; VLC; VLCF; VLCFA; VLCFA C26:0 |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
54295-1 |
Hexanoylcarnitine (C6)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Hexanoylcarnitine (C6)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54295-1 |
|
|
|
|
Both |
|
|
|
0 |
Hexanoylcarn/Creat Ur-sRto |
|
|
|
N |
|
C6; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
54296-9 |
Hexanoylcarnitine (C6) |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Hexanoylcarnitine (C6) [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54296-9 |
|
|
|
|
Both |
|
|
|
0 |
Hexanoylcarn CSF-sCnc |
|
|
|
N |
|
C6; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54297-7 |
Hexanoylcarnitine (C6) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Hexanoylcarnitine (C6) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54297-7 |
|
|
|
|
Both |
|
|
|
0 |
Hexanoylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C6; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |